These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 34535791)

  • 1. Structural biology of SARS-CoV-2 and implications for therapeutic development.
    Yang H; Rao Z
    Nat Rev Microbiol; 2021 Nov; 19(11):685-700. PubMed ID: 34535791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural biology of SARS-CoV-2: open the door for novel therapies.
    Yan W; Zheng Y; Zeng X; He B; Cheng W
    Signal Transduct Target Ther; 2022 Jan; 7(1):26. PubMed ID: 35087058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into SARS-CoV-2 proteins.
    Arya R; Kumari S; Pandey B; Mistry H; Bihani SC; Das A; Prashar V; Gupta GD; Panicker L; Kumar M
    J Mol Biol; 2021 Jan; 433(2):166725. PubMed ID: 33245961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of SARS-CoV-2 genome-encoded proteins.
    Bai C; Zhong Q; Gao GF
    Sci China Life Sci; 2022 Feb; 65(2):280-294. PubMed ID: 34387838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus.
    Baruah C; Devi P; Sharma DK
    Biomed Res Int; 2020; 2020():7234961. PubMed ID: 33102591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus biology and replication: implications for SARS-CoV-2.
    V'kovski P; Kratzel A; Steiner S; Stalder H; Thiel V
    Nat Rev Microbiol; 2021 Mar; 19(3):155-170. PubMed ID: 33116300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
    van de Leemput J; Han Z
    Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular host factors for SARS-CoV-2 infection.
    Baggen J; Vanstreels E; Jansen S; Daelemans D
    Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.
    Rajarshi K; Khan R; Singh MK; Ranjan T; Ray S; Ray S
    Gene; 2021 Feb; 768():145313. PubMed ID: 33220345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.
    Hu J; Stojanović J; Yasamineh S; Yasamineh P; Karuppannan SK; Hussain Dowlath MJ; Serati-Nouri H
    Arch Virol; 2021 Oct; 166(10):2649-2672. PubMed ID: 34278528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of SARS-CoV-2.
    Dërmaku-Sopjani M; Sopjani M
    Curr Mol Med; 2021; 21(7):589-595. PubMed ID: 33272175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential drug targets of SARS-CoV-2: From genomics to therapeutics.
    Shamsi A; Mohammad T; Anwar S; Amani S; Khan MS; Husain FM; Rehman MT; Islam A; Hassan MI
    Int J Biol Macromol; 2021 Apr; 177():1-9. PubMed ID: 33577820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoronaPep: An Anti-Coronavirus Peptide Generation Tool.
    Kaushik AC; Mehmood A; Selvaraj G; Dai X; Pan Y; Wei DQ
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1299-1304. PubMed ID: 33687847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pocket guide on how to structure SARS-CoV-2 drugs and therapies.
    Littler DR; MacLachlan BJ; Watson GM; Vivian JP; Gully BS
    Biochem Soc Trans; 2020 Dec; 48(6):2625-2641. PubMed ID: 33258925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
    Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W
    SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review.
    Bhat EA; Khan J; Sajjad N; Ali A; Aldakeel FM; Mateen A; Alqahtani MS; Syed R
    Int Immunopharmacol; 2021 Jun; 95():107493. PubMed ID: 33721758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.